{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,5,14]],"date-time":"2025-05-14T05:09:28Z","timestamp":1747199368878,"version":"3.40.5"},"reference-count":64,"publisher":"Akademiai Kiado Zrt.","issue":"2","content-domain":{"domain":["akjournals.com"],"crossmark-restriction":true},"short-container-title":["AMicr"],"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>World has been suffering from pandemic caused by mysterious Coronavirus. The novel member of Coronaviridae causing COVID-19 disease is named as SARS-Cov-2. Its first case was reported in China by the end of 2019, but its exponential spread has wrapped entire globe, suspended and is penalizing mankind. A retrospective meta-analysis study showed that outbreaks of Middle East Respiratory Syndrome (MERS) and SARS-Cov-1 (Coronaviridae), influenza infection H1N1 and West-African Ebola caused lower mortality than this new pandemic COVID-19. Virus has appeared as a new human pathogen so to counter COVID-19 no specific vaccine, monoclonal antibodies have been manufactured till day. The outbreak of novel Coronavirus is treated with antimicrobial drugs but they have their own mild side effects. But the drastic spread of COVID-19 compels us also to use other ways to counter pandemic. Thus, passive immunization can be opted to hold back this mysterious virus. Passive immunization has been in use since early 20th century and showed its effectiveness against all previous infectious outbreaks including MERS and SARS-Cov-1 members of Coronaviridae. The review argues that convalescent plasma is an explicit option for containment of COVID-19 disease.<\/jats:p>","DOI":"10.1556\/030.2020.01199","type":"journal-article","created":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T03:12:37Z","timestamp":1598670757000},"page":"87-90","update-policy":"https:\/\/doi.org\/10.1556\/policypage.crossmark.crossref.1","source":"Crossref","is-referenced-by-count":1,"title":["Passive immunization: Paradoxical and traditional method for new pandemic challenge COVID-19"],"prefix":"10.1556","volume":"67","author":[{"given":"Amina","family":"Iftikhar","sequence":"first","affiliation":[{"name":"Department of Zoology, Government College University Faisalabad, Faisalabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2187-6290","authenticated-orcid":true,"given":"Faiza","family":"Jabeen","sequence":"additional","affiliation":[{"name":"Department of Zoology, Government College University Faisalabad, Faisalabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maleeha","family":"Manzoor","sequence":"additional","affiliation":[{"name":"Department of Zoology, Government College University Faisalabad, Faisalabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahira","family":"Younis","sequence":"additional","affiliation":[{"name":"Department of Zoology, Government College University Faisalabad, Faisalabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mussarat","family":"Shaheen","sequence":"additional","affiliation":[{"name":"Department of Zoology, Government College University Faisalabad, Faisalabad, Pakistan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"ref421","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijid.2016.04.008","article-title":"Middle East respiratory syndrome vaccines","volume":"47","author":"Perlman","year":"2016","journal-title":"Int J Infect Dis"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"New Eng J Med"},{"key":"ref241","doi-asserted-by":"crossref","first-page":"72","DOI":"10.12688\/f1000research.22211.2","article-title":"Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China","volume":"9","author":"Kruse","year":"2020","journal-title":"F1000 Res"},{"key":"ref291","doi-asserted-by":"crossref","first-page":"m1256","DOI":"10.1136\/bmj.m1256","article-title":"Covid-19: FDA approves use of convalescent plasma to treat critically ill patients","volume":"368","author":"Tanne","year":"2020","journal-title":"BMJ"},{"key":"ref391","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"ref141","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4940","article-title":"Convalescent plasma to treat COVID-19: possibilities and challenges","author":"Roback","year":"2020","journal-title":"JAMA"},{"volume-title":"Antibodies in the blood of COVID-19 survivors know how to beat coronavirus \u2013 and researchers are already testing new treatments that harness them","year":"2020","author":"Sheehy","key":"ref311"},{"key":"ref571","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.copbio.2019.11.006","article-title":"Simplified monomeric VHH-Fc antibodies provide new opportunities for passive immunization","volume":"61","author":"De Greve","year":"2020","journal-title":"Curr Opin Biotechnol"},{"volume-title":"Antibodies in the blood of COVID-19 survivors know how to beat coronavirus \u2013 and researchers are already testing new treatments that harness them","year":"2020","author":"Sheehy","key":"ref651"},{"key":"ref331","article-title":"Coronavirus drugs: Can antibodies from survivors help?","author":"Freund","year":"2020","journal-title":"Deutsche Welle"},{"key":"ref231","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.copbio.2019.11.006","article-title":"Simplified monomeric VHH-Fc antibodies provide new opportunities for passive immunization","volume":"61","author":"De Greve","year":"2020","journal-title":"Curr Opin Biotechnol"},{"key":"ref121","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/COH.0000000000000154","article-title":"History of passive antibody administration for prevention and treatment of infectious diseases","volume":"10","author":"Graham","year":"2015","journal-title":"Curr Opinion HIV AIDS"},{"key":"ref381","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrmicro775","article-title":"SARS\u2014beginning to understand a new virus","volume":"1","author":"Stadler","year":"2003","journal-title":"Nat Rev Microbiol"},{"volume-title":"Drugmaker Takeda Is Working on Coronavirus Drug","year":"2020","author":"Hopkins","key":"ref411"},{"key":"ref561","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/infdis\/jiw333","article-title":"Passive immunotherapy: assessment of convalescent serum against Ebola virus Makona infection in nonhuman primates","volume":"214","author":"Mire","year":"2016","journal-title":"J Infect Dis"},{"key":"ref671","article-title":"Coronavirus drugs: Can antibodies from survivors help?","author":"Freund","year":"2020","journal-title":"Deutsche Welle"},{"key":"ref581","doi-asserted-by":"crossref","first-page":"72","DOI":"10.12688\/f1000research.22211.2","article-title":"Therapeutic strategies in an outbreak scenario to treat the novel coronavirus originating in Wuhan, China","volume":"9","author":"Kruse","year":"2020","journal-title":"F1000 Res"},{"key":"ref461","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1097\/COH.0000000000000154","article-title":"History of passive antibody administration for prevention and treatment of infectious diseases","volume":"10","author":"Graham","year":"2015","journal-title":"Curr Opinion HIV AIDS"},{"key":"ref211","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jinf.2016.11.009","article-title":"Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone","volume":"74","author":"Sahr","year":"2017","journal-title":"J Infect"},{"key":"ref361","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1056\/NEJMoa1211721","article-title":"Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia","volume":"367","author":"Zaki","year":"2012","journal-title":"New Eng J Med"},{"key":"ref371","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States","volume":"61","author":"Kraft","year":"2015","journal-title":"Clinic Infect Dis"},{"key":"ref501","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archpedi.1946.02020240008001","article-title":"Mumps: use of convalescent serum in the treatment and prophylaxis of orchitis","volume":"71","author":"Rambar","year":"1946","journal-title":"Amer J Dis Child"},{"key":"ref111","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"ref181","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/CCM.0b013e3181d44c1e","article-title":"Hark back: passive immunotherapy for influenza and other serious infections","volume":"38","author":"Luke","year":"2010","journal-title":"Crit care med"},{"key":"ref201","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clinic Infect Dis"},{"key":"ref541","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1093\/cid\/ciq106","article-title":"Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection","volume":"52","author":"Hung","year":"2011","journal-title":"Clinic Infect Dis"},{"key":"ref531","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Inter Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41422-020-0282-0","article-title":"Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro","volume":"30","author":"Wang","year":"2020","journal-title":"Cell Res"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J Clin Invest"},{"key":"ref441","first-page":"152","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano","year":"2016","journal-title":"Blood Trans"},{"key":"ref451","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/infdis\/jiu396","article-title":"The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis","volume":"211","author":"Mair-Jenkins","year":"2015","journal-title":"J Infect Dis"},{"key":"ref101","first-page":"152","article-title":"Convalescent plasma: new evidence for an old therapeutic tool?","volume":"14","author":"Marano","year":"2016","journal-title":"Blood Trans"},{"volume-title":"Why Researchers are exploring antibodies from recovered patients for possible treatment and prevention of COVID-19","year":"2020","author":"Haseltine","key":"ref641"},{"key":"ref491","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.1932.02740650008003","article-title":"Therapeutic use of antipoliomyelitis serum in preparalytic cases of poliomyelitis","volume":"99","author":"Park","year":"1932","journal-title":"J Amer Med Assoc"},{"key":"ref341","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"ref521","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1097\/CCM.0b013e3181d44c1e","article-title":"Hark back: passive immunotherapy for influenza and other serious infections","volume":"38","author":"Luke","year":"2010","journal-title":"Crit care med"},{"key":"ref191","doi-asserted-by":"crossref","first-page":"599","DOI":"10.7326\/0003-4819-145-8-200610170-00139","article-title":"Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment?","volume":"145","author":"Luke","year":"2006","journal-title":"Ann Inter Med"},{"key":"ref431","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13054-020-2786-x","article-title":"Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China","volume":"24","author":"Liu","year":"2020","journal-title":"Crit Care"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/nrmicro775","article-title":"SARS\u2014beginning to understand a new virus","volume":"1","author":"Stadler","year":"2003","journal-title":"Nat Rev Microbiol"},{"volume-title":"Drugmaker Takeda Is Working on Coronavirus Drug","year":"2020","author":"Hopkins","key":"ref71"},{"key":"ref171","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2105\/AJPH.25.5.595","article-title":"Use of convalescent measles serum to control measles in a preparatory school","volume":"25","author":"Gallagher","year":"1935","journal-title":"Amer J Public Health Nations Health"},{"key":"ref01","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A novel coronavirus from patients with pneumonia in China","volume":"382","author":"Zhu","year":"2020","journal-title":"N Engl J Med"},{"key":"ref471","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1093\/cid\/civ334","article-title":"The use of TKM-100802 and convalescent plasma in 2 patients with Ebola virus disease in the United States","volume":"61","author":"Kraft","year":"2015","journal-title":"Clinic Infect Dis"},{"key":"ref351","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N Engl J Med"},{"volume-title":"An EU programme of COVID-19 convalescent plasma collection and transfusion","year":"2020","key":"ref661"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1056\/NEJMoa030781","article-title":"A novel coronavirus associated with severe acute respiratory syndrome","volume":"348","author":"Ksiazek","year":"2003","journal-title":"N Engl J Med"},{"journal-title":"Coronavirus disease (COVID-19)","year":"3 May 2020","key":"ref591"},{"key":"ref261","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25882","article-title":"Treatment with convalescent plasma for COVID\u201019 patients in Wuhan, China","author":"Ye","year":"2020","journal-title":"J Med Virol"},{"key":"ref151","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1001\/jama.1932.02740650008003","article-title":"Therapeutic use of antipoliomyelitis serum in preparalytic cases of poliomyelitis","volume":"99","author":"Park","year":"1932","journal-title":"J Amer Med Assoc"},{"key":"ref81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ijid.2016.04.008","article-title":"Middle East respiratory syndrome vaccines","volume":"47","author":"Perlman","year":"2016","journal-title":"Int J Infect Dis"},{"key":"ref481","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2020.4940","article-title":"Convalescent plasma to treat COVID-19: possibilities and challenges","author":"Roback","year":"2020","journal-title":"JAMA"},{"key":"ref551","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.jinf.2016.11.009","article-title":"Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone","volume":"74","author":"Sahr","year":"2017","journal-title":"J Infect"},{"key":"ref401","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1172\/JCI138003","article-title":"The convalescent sera option for containing COVID-19","volume":"130","author":"Casadevall","year":"2020","journal-title":"J Clin Invest"},{"key":"ref601","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.25882","article-title":"Treatment with convalescent plasma for COVID\u201019 patients in Wuhan, China","author":"Ye","year":"2020","journal-title":"J Med Virol"},{"journal-title":"Coronavirus disease (COVID-19)","year":"3 May 2020","key":"ref251"},{"volume-title":"An EU programme of COVID-19 convalescent plasma collection and transfusion","year":"2020","key":"ref321"},{"key":"ref161","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/archpedi.1946.02020240008001","article-title":"Mumps: use of convalescent serum in the treatment and prophylaxis of orchitis","volume":"71","author":"Rambar","year":"1946","journal-title":"Amer J Dis Child"},{"key":"ref221","doi-asserted-by":"crossref","first-page":"S367","DOI":"10.1093\/infdis\/jiw333","article-title":"Passive immunotherapy: assessment of convalescent serum against Ebola virus Makona infection in nonhuman primates","volume":"214","author":"Mire","year":"2016","journal-title":"J Infect Dis"},{"key":"ref91","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13054-020-2786-x","article-title":"Critical care response to a hospital outbreak of the 2019-nCoV infection in Shenzhen, China","volume":"24","author":"Liu","year":"2020","journal-title":"Crit Care"},{"key":"ref631","doi-asserted-by":"crossref","first-page":"m1256","DOI":"10.1136\/bmj.m1256","article-title":"Covid-19: FDA approves use of convalescent plasma to treat critically ill patients","volume":"368","author":"Tanne","year":"2020","journal-title":"BMJ"},{"key":"ref131","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.1001\/jama.2020.4783","article-title":"Treatment of 5 critically Ill patients with COVID-19 with convalescent plasma","volume":"323","author":"Shen","year":"2020","journal-title":"JAMA"},{"key":"ref511","doi-asserted-by":"crossref","first-page":"595","DOI":"10.2105\/AJPH.25.5.595","article-title":"Use of convalescent measles serum to control measles in a preparatory school","volume":"25","author":"Gallagher","year":"1935","journal-title":"Amer J Public Health Nations Health"},{"volume-title":"Why Researchers are exploring antibodies from recovered patients for possible treatment and prevention of COVID-19","year":"2020","author":"Haseltine","key":"ref301"}],"container-title":["Acta Microbiologica et Immunologica Hungarica"],"original-title":[],"link":[{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/67\/2\/article-p87.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/akjournals.com\/downloadpdf\/journals\/030\/67\/2\/article-p87.xml","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,3]],"date-time":"2022-05-03T01:31:56Z","timestamp":1651541516000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/view\/journals\/030\/67\/2\/article-p87.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6]]},"references-count":64,"journal-issue":{"issue":"2"},"URL":"https:\/\/doi.org\/10.1556\/030.2020.01199","relation":{},"ISSN":["1217-8950","1588-2640"],"issn-type":[{"type":"print","value":"1217-8950"},{"type":"electronic","value":"1588-2640"}],"subject":[],"published":{"date-parts":[[2020,6]]}}}